View in EDS

368TiPSTART: A randomized phase II study in patients with triple negative, androgen receptor positive locally recurrent (unresectable) or metastatic breast cancer treated with darolutamide or capecitabine (UCBG-306).

Saved in:
Bibliographic Details
Title: 368TiPSTART: A randomized phase II study in patients with triple negative, androgen receptor positive locally recurrent (unresectable) or metastatic breast cancer treated with darolutamide or capecitabine (UCBG-306).
Authors: Bonnefoi, H1 (AUTHOR), Levy, C2 (AUTHOR), MacGrogan, G3 (AUTHOR), Grellety, T1 (AUTHOR), Asselain, B4 (AUTHOR), Pulido, M5 (AUTHOR), Everhard, S6 (AUTHOR), Lemonnier, J6 (AUTHOR), Gonçalves, A7 (AUTHOR)
Source: Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 133286174
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 368TiPSTART: A randomized phase II study in patients with triple negative, androgen receptor positive locally recurrent (unresectable) or metastatic breast cancer treated with darolutamide or capecitabine (UCBG-306).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Bonnefoi%2C+H%22">Bonnefoi, H</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Levy%2C+C%22">Levy, C</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22MacGrogan%2C+G%22">MacGrogan, G</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Grellety%2C+T%22">Grellety, T</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Asselain%2C+B%22">Asselain, B</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pulido%2C+M%22">Pulido, M</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Everhard%2C+S%22">Everhard, S</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lemonnier%2C+J%22">Lemonnier, J</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gonçalves%2C+A%22">Gonçalves, A</searchLink><relatesTo>7</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=133286174
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/annonc/mdy272.356
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: N.PAG
    Titles:
      – TitleFull: 368TiPSTART: A randomized phase II study in patients with triple negative, androgen receptor positive locally recurrent (unresectable) or metastatic breast cancer treated with darolutamide or capecitabine (UCBG-306).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bonnefoi, H
      – PersonEntity:
          Name:
            NameFull: Levy, C
      – PersonEntity:
          Name:
            NameFull: MacGrogan, G
      – PersonEntity:
          Name:
            NameFull: Grellety, T
      – PersonEntity:
          Name:
            NameFull: Asselain, B
      – PersonEntity:
          Name:
            NameFull: Pulido, M
      – PersonEntity:
          Name:
            NameFull: Everhard, S
      – PersonEntity:
          Name:
            NameFull: Lemonnier, J
      – PersonEntity:
          Name:
            NameFull: Gonçalves, A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 10
              Text: 2018 Supplement
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 29
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1